Author

M. Crosby

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:rat· 1

Frequent Co-Authors

B. Moriarity· 1 shared B. Smeester· 1 shared B. v. d. Water· 1 shared C. Fisher· 1 shared C. Pont· 1 shared D. Clausznitzer· 1 shared D. Largaespada· 1 shared D. Odde· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Moriarity

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatio-temporal transcriptomic analysis reveals distinct nephrotoxicity, DNA damage and regeneration response after cisplatin

L. S. Wijaya, S. Kunnen, P. Trairatphisan, C. Fisher, M. Crosby, K. Schaefer, K. Bodie, E. Vaughan, L. Breidenbach, T. Reich, D. Clausznitzer, S. A. Bonnet, S. Zheng, C. Pont, J. L. Stevens, , B. v. d. Water

This study uses spatial transcriptomics to analyze cisplatin-induced nephrotoxicity and regeneration in different kidney segments, identifying distinct molecular responses and biomarkers.

bioRxiv · Jan 3, 2023Pharmacology & Toxicology

SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

B. Smeester, N. Slipek, E. Pomeroy, H. Bomberger, G. Shamsan, J. Peterson, M. Crosby, G. Draper, K. Becklin, E. Rahrmann, J. McCarthy, D. Odde, D. Wood, D. Largaespada, B. Moriarity

This study shows SEMA4C promotes osteosarcoma growth and metastasis, with its inhibition reducing tumor progression and suggesting clinical potential.

bioRxiv · Jan 14, 2019Cancer Biology